Stereotactic body radiation therapy for lung cancer

Chest

Volumn 143, Issue 6, 2013, Pages 1784-1790

  Simone II, Charles B ^a   Wildt, Brian ^a   Haas, Andrew R ^a   Pope, Greg ^a   Rengan, Ramesh ^a   Hahn, Stephen M ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRONCHUS STENOSIS; CANCER PATIENT; CANCER STAGING; COUGHING; CRYOTHERAPY; ERYTHEMA; ESOPHAGUS INJURY; FATIGUE; HEALTH SERVICE; HEMATOLOGIC DISEASE; HEMOPTYSIS; HOSPITAL MANAGEMENT; HUMAN; HYPOXIA; LOBECTOMY; LUNG DISEASE; LUNG FIBROSIS; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; RADIOFREQUENCY ABLATION; RIB FRACTURE; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC RADIOSURGERY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; WEDGE RESECTION;

EID: 84878549501     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-2580     Document Type: Article

References (42)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10-29.
2. Howlader N, Noone AM, Krapcho M, et al, eds. SEER cancer statistics review 1975-2009(vintage 2009 populations). National Cancer Institute website. http://seer.cancer.gov/csr/1975-2009-pops09. Updated August 20, 2012. Accessed September 18, 2012.
3. Groome PA, Bolejack V, Crowley JJ, et al; IASLC International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007;2(8):694-705.
4. Aberle DR, Adams AM, Berg CD, et al; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395-409.
5. Robinson CG, Bradley JD. The treatment of early-stage disease . Semin Radiat Oncol. 2010;20(3):178-185.
6. American Medical Association. The RVS Update Committee. American Medical Association website. http://www.ama-assn.org/ama/home.page. Accessed September 18, 2012.
7. Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman BJ, Senan S. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. J Clin Oncol. 2010;28(35):5153-5159.
8. Rosenzweig KE, Movsas B, Bradley J, et al. ACR appropriateness criteria on nonsurgical treatment for non-smallcell lung cancer: poor performance status or palliative intent. J Am Coll Radiol. 2009;6(2):85-95.
9. Smythe WR; American College of Chest Physicians. Treatment of stage I non-small cell lung carcinoma. Chest. 2003;123(supp 1):181S-187S.
10. Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K; American College of Chest Physicians. Treatment of nonsmall cell lung cancer stage I and stage II: ACCP evidencebased clinical practice guidelines (2nd edition). Chest. 2007;132(suppl 3):234S-242S.
11. Sandler HM, Curran WJ Jr, Turrisi AT III. The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1990;19(1):9-13.
12. Kaskowitz L, Graham MV, Emami B, Halverson KJ, Rush C. Radiation therapy alone for stage I non-small cell lung cancer . Int J Radiat Oncol Biol Phys. 1993;27(3):517-523.
13. Flehinger BJ, Kimmel M, Melamed MR. The effect of surgical treatment on survival from early lung cancer. Implications for screening. Chest. 1992;101(4):1013-1018.
14. Kraev A, Rassias D, Vetto J, et al. Wedge resection vs lobectomy:10-year survival in stage I primary lung cancer. Chest. 2007;131(1):136-140.
15. Deslauriers J, Grégoire J. Surgical therapy of early non-small cell lung cancer. Chest. 2000;117(4)(suppl 1):104S-109S.
16. Bradley JD, Wahab S, Lockett MA, Perez CA, Purdy JA. Elective nodal failures are uncommon in medically inoperable patients with Stage I non-small-cell lung carcinoma treated with limited radiotherapy fields. Int J Radiat Oncol Biol Phys. 2003;56(2):342-347.
17. Slotman BJ, Antonisse IE, Njo KH. Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer. Radiother Oncol. 1996;41(1):41-44.
18. Bogart JA, Hodgson L, Seagren SL, et al. Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904. J Clin Oncol. 2010;28(2):202-206.
19. Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand. 1951;102(4):316-319.
20. Potters L, Kavanagh B, Galvin JM, et al; American Society for Therapeutic Radiology and Oncology; American College of Radiology. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2010;76(2):326-332.
21. Hurkmans CW, Cuijpers JP, Lagerwaard FJ, et al. Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study. Radiat Oncol. 2009;4:1.
22. McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage nonsmall-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys. 2005;63(4):1010-1015.
23. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable earlystage lung cancer. J Clin Oncol. 2006;24(30):4833-4839.
24. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303(11):1070-1076.
25. Onishi H, Shirato H, Nagata Y, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol. 2007;2(7)(suppl 3): S94-S100.
26. Ricardi U, Filippi AR, Guarneri A, et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial. Lung Cancer. 2010;68(1):72-77.
27. Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospec tive phase II trial of medically inoperable stage I nonsmall-cell lung cancer patients treated with stereotactic body radio therapy. J Clin Oncol. 2009;27(20):3290-3296.
28. Fakiris AJ, McGarry RC, Yiannoutsos CT, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys. 2009;75(3):677-682.
29. Koto M, Takai Y, Ogawa Y, et al. A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer . Radiother Oncol. 2007;85(3):429-434.
30. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2005;63(5):1427-1431.
31. Ginsberg RJ, Rubinstein LV; Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg. 1995;60(3):615-622.
32. Alberts WM; American College of Chest Physicians. Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(suppl 3):1S-19S.
33. Palma D, Senan S. Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer. Curr Opin Oncol. 2011;23(2):133-139.
34. Senan S, Palma DA, Lagerwaard FJ. Stereotactic ablative radiotherapy for stage I NSCLC: recent advances and controversies . J Thorac Dis. 2011;3(3):189-196.
35. Onishi H, Shirato H, Nagata Y, et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys. 2011;81(5):1352-1358.
36. Grills IS, Mangona VS, Welsh R, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I nonsmall-cell lung cancer. J Clin Oncol. 2010;28(6):928-935.
37. National Institutes of Health. Search for studies. ClinicalTrials. gov website. http://clinicaltrials.gov. Accessed September 18, 2012.
38. Siva S, MacManus M, Ball D. Stereotactic radiotherapy for pulmonary oligometastases: a systematic review. J Thorac Oncol. 2010;5(7):1091-1099.
39. Haasbeek CJ, Lagerwaard FJ, Slotman BJ, Senan S. Outcomes of stereotactic ablative radiotherapy for centrally located earlystage lung cancer. J Thorac Oncol. 2011;6(12):2036-2043.
40. Rubins J, Unger M, Colice GL; American College of Chest Physicians . Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition). Chest. 2007;132(suppl 3):355S-367S.
41. Centers for Medicare & Medicaid Services. Medicare Centers for Medicare & Medicaid Services website. Available at http://www.cms.gov/ Medicare/Medicare.html. Accessed September 18, 2012.
42. American Society for Radiation Oncology and American College of Radiology. Stereotactic Body Radiation Therapy. 2012 ASTRO/ACR Guide to Radiation Oncology Coding. Fairfax, VA: American Society for Radiation Oncology;2012.